VKVera Krump-Konvalinkova

Vera Krump-Konvalinkova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vera Krump-Konvalinkova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • C. James Kirkpatrick

    From the Institute for Prevention of Cardiovascular Diseases (V.K.-K., T.R., W.A., C.V., W.S.), Ludwig Maximilian University, Munich, Germany; the Department of Physiology (S.Y., N.M., G.T.), University of Tennessee Health Science Center, Memphis; the Institute of Medical Microbiology, Immunology and Hygiene (J.M.), Technical University, Munich, Germany; and the Institute of Pathology (C.J.D.), Johannes Gutenberg University, Mainz, Germany

    2 shared publications
  • Claudia Vosseler

    From the Institute for Prevention of Cardiovascular Diseases (V.K.-K., T.R., W.A., C.V., W.S.), Ludwig Maximilian University, Munich, Germany; the Department of Physiology (S.Y., N.M., G.T.), University of Tennessee Health Science Center, Memphis; the Institute of Medical Microbiology, Immunology and Hygiene (J.M.), Technical University, Munich, Germany; and the Institute of Pathology (C.J.D.), Johannes Gutenberg University, Mainz, Germany

    1 shared publication
  • Fernando Bittinger

    1 shared publication
  • Gabor Tigyi

    From the Institute for Prevention of Cardiovascular Diseases (V.K.-K., T.R., W.A., C.V., W.S.), Ludwig Maximilian University, Munich, Germany; the Department of Physiology (S.Y., N.M., G.T.), University of Tennessee Health Science Center, Memphis; the Institute of Medical Microbiology, Immunology and Hygiene (J.M.), Technical University, Munich, Germany; and the Institute of Pathology (C.J.D.), Johannes Gutenberg University, Mainz, Germany

    1 shared publication
  • Joachim Brunner

    1 shared publication
  • Jörg Mages

    From the Institute for Prevention of Cardiovascular Diseases (V.K.-K., T.R., W.A., C.V., W.S.), Ludwig Maximilian University, Munich, Germany; the Department of Physiology (S.Y., N.M., G.T.), University of Tennessee Health Science Center, Memphis; the Institute of Medical Microbiology, Immunology and Hygiene (J.M.), Technical University, Munich, Germany; and the Institute of Pathology (C.J.D.), Johannes Gutenberg University, Mainz, Germany

    1 shared publication

Latest Publications

  • Stable Knock-Down of the Sphingosine 1-Phosphate Receptor S1P 1 Influences Multiple Functions of Human Endothelial Cells

    by Vera Krump-Konvalinkova, Satoshi Yasuda, Tina Rubic, Natalia Makarova, Jörg Mages, Wolfgang Erl, Claudia Vosseler, C. James Kirkpatrick, Gabor Tigyi, Wolfgang Siess

    Objectives— Sphingosine 1-phosphate (S1P) is a bioactive phospholipid acting both as a ligand for the G protein–coupled receptors S1P 1-5 and as a second messenger. Because S1P 1 knockout is lethal in the transgenic mouse, an alternative approach to study the function of S1P 1 in endothelial cells is needed. Methods and Results— All human endothelial cells analyzed expressed abundant S1P 1 transcripts. We permanently silenced (by RNA interference) the expression of S1P 1 in the human endothelial cell lines AS-M.5 and ISO-HAS.1. The S1P 1 knock-down cells manifested a distinct morphology and showed neither actin ruffles in response to S1P nor an angiogenic reaction. In addition, these cells were more sensitive to oxidant stress–mediated injury. New S1P 1 -dependent gene targets were identified in human endothelial cells. S1P 1 silencing decreased the expression of platelet–endothelial cell adhesion molecule-1 and VE-cadherin and abolished the induction of E-selectin after cell stimulation with lipopolysaccharide or tumor necrosis factor-α. Microarray analysis revealed downregulation of further endothelial specific transcripts after S1P 1 silencing. Conclusions— Long-term silencing of S1P 1 enabled us for the first time to demonstrate the involvement of S1P 1 in key functions of endothelial cells and to identify new S1P 1 -dependent gene targets.


  • Establishment and Characterization of an Angiosarcoma-Derived Cell Line, AS-M

    by Vera Krump-Konvalinkova, Fernando Bittinger, Jürgen Olert, Wolfgang Bräuninger, Joachim Brunner, C. James Kirkpatrick

    A novel human endothelial cell line, AS-M, has been established from a cutaneous angiosarcoma on the scalp. The cells expressing platelet endothelial cell adhesion molecule-1 (CD31) were isolated using magnetic beads and subsequently cultured for a year. To date, the cells have undergone more than 100 population doublings (PDs). The AS-M cells manifested endothelial characteristics, such as active uptake of acetylated low-density lipoprotein labeled with 1,1'-dioctadecyl 3,3,3',3'-tetramethylindocarbocyanine perchlorate (Dil-Ac-LDL), capacity to bind the Ulex europeaus agglutin-I (UEA-I), and expression of von Willebrand factor (vWF) and CD31. The single cell-derived clone, AS-M.5, showed a constitutive expression of CD31, vWF, angiotensin-converting enzyme (ACE), endoglin (CD105), and the endothelial cell receptor tyrosine kinases KDR and Tie-1. Similarly to freshly isolated endothelial cells, the AS-M.5 responded to induction by bacterial lipopolysaccharide (LPS) by increased transcription of cell adhesion molecules and cytokines. The AS-M.5 cultures required endothelial growth supplements for optimal growth and long-term propagation in vitro. However, in contrast to normal endothelial cells, p53 gene products were detected in nuclei of AS-M.5 cells. Cytogenetic analyses consistently revealed a hypodiploid karyotype with complete loss of one homologue of several chromosomes and a homogeneous pattern of distinct karyotypic changes. Although the AS-M.5 presented characteristics suggestive of tumor cells, they did not develop into tumors when inoculated subcutaneously into nude mice. The cell line AS-M.5 could be a useful model system to study endothelial pathobiology in vitro.